TFS Forms Partnership to Conduct a Global RWE Study on Covid-19 Pandemic

Coronavirus disease 2019 (COVID-19) pandemic has an urgent need for answering many questions regarding epidemiology and natural history of the disease. Neus Valveny, TFS Operational Strategy Lead Real World Evidence, addresses the importance of real world evidence to complement clinical trial results. "Similarities and differences with other viral infections as well as effectiveness and safety of current preventive or therapeutic measures are extremely important. Models assessing most relevant prognostic factors in the daily practice will be also crucial to help healthcare providers decide which subjects should be prioritized and given more intensive therapies. The full analysis needs to be adjusted for potential confounding and biases inherent to observational research."

Coronavirus disease 2019 (COVID-19) pandemic has an urgent need for answering many questions regarding epidemiology and natural history of the disease. Neus Valveny, TFS Operational Strategy Lead Real World Evidence, addresses the importance of real world evidence to complement clinical trial results. "Similarities and differences with other viral infections as well as effectiveness and safety of current preventive or therapeutic measures are extremely important. Models assessing most relevant prognostic factors in the daily practice will be also crucial to help healthcare providers decide which subjects should be prioritized and given more intensive therapies. The full analysis needs to be adjusted for potential confounding and biases inherent to observational research."

For further information, please contact:

Sylwia Domagalska
Director Marketing and Corporate Communications
Email: [email protected] 
Phone: +48-787-913-074

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/tfs/r/tfs-forms-partnership-to-conduct-a-global-rwe-study-on-covid-19-pandemic-,c3078702

The following files are available for download: